Ensign Peak Advisors, Inc Eli Lilly & CO Transaction History

Ensign Peak Advisors, Inc

$54.2 Billion
Q2 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 891,915 shares of LLY stock, worth $811 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

891,915

Previous 927,254 3.81%

Holding current value

$811 Million

Previous $721 Million 11.94%

% of portfolio

1.49%

Previous 1.33%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $25.6 Million - $32.1 Million	-35,339 Reduced 3.81%	891,915 $808 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $131 Million - $175 Million	221,327 Added 31.35%	927,254 $721 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $61.8 Million - $72.9 Million	117,708 Added 20.01%	705,927 $411 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $125 Million - $173 Million	-288,166 Reduced 32.88%	588,219 $316 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $58.7 Million - $78.5 Million	167,426 Added 23.62%	876,385 $411 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $90.3 Million - $106 Million	290,645 Added 69.48%	708,959 $243 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $9.71 Million - $11.3 Million	30,207 Added 7.78%	418,314 $153 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $32.5 Million - $37 Million	109,602 Added 39.35%	388,107 $125 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $61.9 Million - $72.6 Million	-221,910 Reduced 44.35%	278,505 $90.3 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $33.7 Million - $41.9 Million	-143,781 Reduced 22.32%	500,415 $143 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $7.54 Million - $9.36 Million	-33,543 Reduced 4.95%	644,196 $178 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $72.6 Million - $89.3 Million	-327,396 Reduced 32.57%	677,739 $157 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $8.1 Million - $10.5 Million	-44,851 Reduced 4.27%	1,005,135 $231 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $45.8 Million - $59.3 Million	278,594 Added 36.12%	1,049,986 $196 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $9.85 Million - $13 Million	-75,535 Reduced 8.92%	771,392 $130 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $4.66 Million - $5.39 Million	31,871 Added 3.91%	846,927 $125 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $75 Million - $90.3 Million	549,775 Added 207.24%	815,056 $134 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $3.72 Million - $4.61 Million	-31,253 Reduced 10.54%	265,281 $36.8 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $31.7 Million - $39.3 Million	296,534 New	296,534 $39 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Eli Lilly & CO Transaction History